Xiao-ming Jiang

发表

Platycodin D triggers the extracellular release of programed death Ligand-1 in lung cancer cells.

Jin-jian Lu, Mu-yang Huang, Xiao-ming Jiang, 2019, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Methylation in esophageal carcinogenesis.

Xiao-ming Jiang, Da-Long Wu, F. Sui, 2006, World journal of gastroenterology.

Nagilactone E increases PD-L1 expression through activation of c-Jun in lung cancer cells.

Jin-jian Lu, Mu-yang Huang, Xiao-ming Jiang, 2020, Chinese journal of natural medicines.

Glutathione peroxidase 8 expression on cancer cells and cancer‐associated fibroblasts facilitates lung cancer metastasis

Mu-yang Huang, Xiao-ming Jiang, Yu-lian Xu, 2022, MedComm.

c-MYC-mediated TRIB3/P62+ aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2

Jin-jian Lu, Mu-yang Huang, Xiao-ming Jiang, 2021, Acta pharmaceutica Sinica. B.

Phanginin R Induces Cytoprotective Autophagy via JNK/c-Jun Signaling Pathway in Non-Small Cell Lung Cancer A549 Cells.

Jin-jian Lu, Xiao-ming Jiang, Yu-lian Xu, 2020, Anti-cancer agents in medicinal chemistry.

Nagilactone E suppresses TGF-β1-induced epithelial-mesenchymal transition, migration and invasion in non-small cell lung cancer cells.

Jin-jian Lu, Mu-yang Huang, Xiao-ming Jiang, 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Activation of notch 3/c-MYC/CHOP axis regulates apoptosis and promotes sensitivity of lung cancer cells to mTOR inhibitor everolimus.

Jin-jian Lu, Xiao-ming Jiang, Yu-lian Xu, 2020, Biochemical pharmacology.

TGFβ2-mediated epithelial–mesenchymal transition and NF-κB pathway activation contribute to osimertinib resistance

Jin-jian Lu, Mu-yang Huang, Xiao-ming Jiang, 2020, Acta Pharmacologica Sinica.

Characterization of osimertinib (AZD9291)-resistant non-small cell lung cancer NCI-H1975/OSIR cell line

Jin-jian Lu, Xiao-ming Jiang, Xiuping Chen, 2016, Oncotarget.

Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms.

Jin-jian Lu, Mu-yang Huang, Xiao-ming Jiang, 2020, Pharmacology & therapeutics.

TGFβ2-mediated epithelial–mesenchymal transition and NF-κB pathway activation contribute to osimertinib resistance

Mu-yang Huang, Xiao-ming Jiang, Yu-lian Xu, 2020, Acta Pharmacologica Sinica.

Downregulation of Cyclin B1 mediates nagilactone E‐induced G2 phase cell cycle arrest in non‐small cell lung cancer cells

Jin-jian Lu, Xiao-ming Jiang, Yitao Wang, 2018, European journal of pharmacology.

Identification of nagilactone E as a protein synthesis inhibitor with anticancer activity

Jin-jian Lu, Xiao-ming Jiang, Yitao Wang, 2020, Acta Pharmacologica Sinica.

Osimertinib (AZD9291) decreases programmed death ligand-1 in EGFR-mutated non-small cell lung cancer cells

Jin-jian Lu, Mu-yang Huang, Xiao-ming Jiang, 2017, Acta Pharmacologica Sinica.

Expression of ATP7B in human gastric cardiac carcinomas in comparison with distal gastric carcinomas.

Xiao-ming Jiang, Da-Long Wu, F. Sui, 2006, World journal of gastroenterology.

Human keratinocyte carcinomas have distinct differences in their tumor-associated macrophages

Xiao-ming Jiang, S. Book, O. Colegio, 2019, Heliyon.

Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells.

Jin-jian Lu, Mu-yang Huang, Xiao-ming Jiang, 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Establishment and Characterization of Pemetrexed-Resistant NCI-H460/PMT Cells.

Jin-jian Lu, Xiao-ming Jiang, Yu-lian Xu, 2019, Anti-cancer agents in medicinal chemistry.

Regulation of CD47 expression by interferon-gamma in cancer cells

Jin-jian Lu, Mu-yang Huang, Xiao-ming Jiang, 2021, Translational oncology.

Identification of nagilactone E as a protein synthesis inhibitor with anticancer activity

Jin-jian Lu, Xiao-ming Jiang, Yitao Wang, 2020, Acta Pharmacologica Sinica.

Increased Expression of IRE1α Associates with the Resistant Mechanism of Osimertinib (AZD9291)-resistant non-small Cell Lung Cancer HCC827/OSIR Cells.

Jin-jian Lu, Xiao-ming Jiang, Xiuping Chen, 2017, Anti-cancer agents in medicinal chemistry.